Akebia director granted RSUs and stock options
Akebia Therapeutics, Inc. reported that director Michael W. Rogers received new equity awards.
Rhea-AI Filing Summary
Akebia Therapeutics, Inc. reported that director Michael W. Rogers received new equity awards. He acquired 35,700 shares of common stock in the form of restricted stock units granted at no cash cost and not yet vested. He also received a stock option for 53,600 shares of common stock with an exercise price of $1.02 per share. Both the RSUs and the option vest in full on the first anniversary of the June 17, 2026 grant date, or immediately before the first annual stockholder meeting after that date, if earlier, subject to his continuous service. Following these awards, he directly holds 197,429 shares of common stock and 53,600 stock options.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 89,300 shares
Grant/Award
2 txns
Insider
ROGERS MICHAEL W
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to buy) | 53,600 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 35,700 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to buy) — 53,600 contracts (Direct);
Common Stock — 197,429 shares (Direct)
Footnotes (2)
- F1. The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Fifth Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continuous service to the Issuer through such vesting date.
- F2. The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continuous service to the Issuer through such vesting date.
Key Figures
RSUs granted: 35,700 shares
Stock option granted: 53,600 shares
Option exercise price: $1.02 per share
+3 more
6 metrics
RSUs granted
35,700 shares
Restricted stock units granted to director on June 17, 2026
Stock option granted
53,600 shares
Option to buy common stock granted to director
Option exercise price
$1.02 per share
Exercise price of newly granted stock option
Shares held after grant
197,429 shares
Common stock directly owned following RSU grant
Option vesting
100% after one year
Stock option vests in full on first anniversary or earlier annual meeting
RSU vesting
100% after one year
RSUs vest in full on first anniversary or earlier annual meeting
Key Terms
restricted stock units, 2023 Stock Incentive Plan, Non-Employee Director Compensation Program, Stock Option, +1 more
5 terms
restricted stock units financial
"The restricted stock units (the "RSUs") were granted by the Issuer"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
2023 Stock Incentive Plan financial
"were granted by the Issuer pursuant to its 2023 Stock Incentive Plan"
Non-Employee Director Compensation Program financial
"as provided by the Issuer's Fifth Amended and Restated Non-Employee Director Compensation Program"
Stock Option financial
"The option to purchase shares of the Issuer's common stock (the "Stock Option")"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
continuous service financial
"subject to the Reporting Person's continuous service to the Issuer through such vesting date"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Akebia Therapeutics (AKBA) director Michael W. Rogers receive?
Michael W. Rogers received 35,700 restricted stock units and a stock option for 53,600 shares. The option has a $1.02 exercise price and both awards were granted under Akebia’s 2023 Stock Incentive Plan and its non-employee director compensation program.
When do Michael W. Rogers’ new Akebia (AKBA) RSUs and options vest?
Both the 35,700 RSUs and the 53,600-share stock option vest 100% on the first anniversary of the June 17, 2026 grant date. Vesting can occur earlier, immediately before the first annual stockholder meeting after grant, if he remains in continuous service.
What is the exercise price of Michael W. Rogers’ new Akebia (AKBA) stock option?
The new stock option granted to Michael W. Rogers has an exercise price of $1.02 per share. It covers 53,600 shares of Akebia common stock and becomes fully exercisable upon vesting under the company’s 2023 Stock Incentive Plan framework.
Under which plan were Michael W. Rogers’ Akebia (AKBA) awards granted?
The RSUs and stock option were granted under Akebia’s 2023 Stock Incentive Plan. They were provided pursuant to the company’s Fifth Amended and Restated Non-Employee Director Compensation Program, which governs equity compensation for outside board members.
AI-generated analysis. How Rhea-AI works. Not financial advice.
